All In Biotech

Free tool

FAERS Monitor: Plaquenil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 009768 or its brand name (Plaquenil, Hydroxychloroquine Sulfate). Reports on generic versions are filed under their own applications.

Reports

91,641

Serious

68,992

75% of reports

Hospitalization

22,904

Death reported

6,486

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective29,383
  • rheumatoid arthritis20,611
  • pain16,841
  • fatigue14,367
  • arthralgia14,050
  • drug intolerance12,522
  • joint swelling12,435
  • off label use11,521
  • rash10,890
  • abdominal discomfort9,834
  • contraindicated product administered9,728
  • alopecia9,672
  • nausea9,604
  • systemic lupus erythematosus9,038
  • arthropathy8,976

Reports by year received

View as table
YearReports
2004639
2005603
2006927
20071,419
20081,525
20091,621
20101,439
20111,640
20122,381
20132,084
20142,448
20154,032
20164,898
20175,675
20186,669
20198,373
202012,455
20218,013
20226,960
20234,564
20245,329
20255,007
20262,940

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,962,518 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contraindicated product administeredSignal9,728108.1105.6702,026
systemic lupus erythematosusSignal9,03878.076.3513,332
rheumatoid arthritisSignal20,61150.750.0826,075
arthropathySignal8,97644.043.1317,119
drug intoleranceSignal12,52234.033.4351,018
joint swellingSignal12,43526.225.8272,382
abdominal discomfortSignal9,83414.214.0114,776
alopeciaSignal9,67211.811.692,088
arthralgiaSignal14,0508.07.984,707
painSignal16,8416.46.477,552
rashSignal10,8905.95.843,647
drug ineffectiveSignal29,3835.25.2104,285
fatigueSignal14,3674.34.237,030
off label useSignal11,5213.03.016,309
nauseaSignal9,6042.82.811,466

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.